Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 32.34
0.124 %
$ 1.81 B
Market Cap
29.14
P/E
SUPN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities SUPN - Supernus Pharmaceuticals, Inc.
12.2 M
LAST VALUE
77.87%
2 YEAR CAGR
25.43%
5 YEAR CAGR
35.84%
10 YEAR CAGR